Global Virus Filtration Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Technology;

Filtration, and Chromatography.

By Application;

Biologicals, Medical Devices, and Water Purification.

By Product;

Consumables, Instruments, and Services.

By End-User;

Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, Contract Testing Organizations, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn157931411 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Virus Filtration Market (USD Million), 2021 - 2031

In the year 2023, the Global Virus Filtration Market was valued at USD 4,643.57 million. The size of this market is expected to increase to USD 10,201.46 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 11.9%.

Virus filtration techniques are employed to remove or inactivate viral contaminants from biopharmaceutical preparations, ensuring the safety, purity, and efficacy of the final products. This market plays a vital role in safeguarding public health by minimizing the risk of viral transmission through therapeutic agents and ensuring compliance with stringent regulatory requirements.

At the heart of the Global Virus Filtration Market lies the imperative to mitigate the risk of viral contamination in biopharmaceutical manufacturing processes. Viruses pose a significant threat to the safety of biologics and vaccines, potentially causing adverse effects in patients and compromising product quality. Virus filtration serves as a robust and reliable method for removing viral particles from biopharmaceutical formulations, cell culture media, and process intermediates, thereby safeguarding the integrity of the final products and protecting patient safety.

The growth of the Global Virus Filtration Market is propelled by several key factors. Firstly, the increasing demand for biologics, including monoclonal antibodies, recombinant proteins, and viral vaccines, drives the need for effective viral clearance solutions in biopharmaceutical manufacturing. As biologics continue to gain prominence in the treatment of various diseases, ensuring viral safety becomes paramount to meet regulatory requirements and maintain product quality standards.

Advancements in filtration technologies and manufacturing processes enhance the efficiency, reliability, and scalability of virus filtration methods. Innovative filtration systems, membrane materials, and virus removal strategies enable biopharmaceutical companies to achieve high levels of viral clearance while optimizing process efficiency and productivity. These technological advancements empower manufacturers to meet the evolving needs of the biopharmaceutical industry and address emerging viral threats effectively.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By Application
    3. Market Snapshot, By Product
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Global Virus Filtration Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Demand for Biopharmaceuticals

        2. Stringent Regulatory Requirements for Viral Safety

        3. Advancements in Filtration Technologies

      2. Restraints
        1. High Cost of Virus Filtration Processes

        2. Potential Impact on Product Integrity

        3. Limited Scalability of Filtration Systems

      3. Opportunities
        1. Expansion of Biologics Manufacturing

        2. Growing Emphasis on Vaccine Development

        3. Adoption of Single-Use Filtration Systems

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Virus Filtration Market, By Technology, 2021 - 2031 (USD Million)
      1. Filtration

      2. Chromatography

    2. Global Virus Filtration Market, By Application, 2021 - 2031 (USD Million)
      1. Biologicals

      2. Medical Devices

      3. Water Purification

    3. Global Virus Filtration Market, By Product, 2021 - 2031 (USD Million)
      1. Consumables
      2. Instruments
      3. Services
    4. Global Virus Filtration Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals and Clinics

      2. Pharmaceutical Companies

      3. Medical Device Companies

      4. Contract Testing Organizations

      5. Others

    5. Global Virus Filtration Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Merck KGaA
      2. Danaher
      3. Sartorius AG
      4. Thermo Fisher Scientific Inc
      5. GE Healthcare
      6. Charles River Laboratories
      7. Asahi Kasei Medical Co Ltd
      8. WuXi AppTec
      9. Lonza
      10. Clean Biologics
  7. Analyst Views
  8. Future Outlook of the Market